ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LGND Ligand Pharmaceuticals Incorporated

72.47
-0.05 (-0.07%)
20 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -0.07% 72.47 10:00:00
Open Price Low Price High Price Close Price Previous Close
71.93 71.16 72.95 72.47 72.52
more quote information »

Recent News

Date Time Source Heading
08/3/202405:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202409:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202410:12EDGAR2Form 144 - Report of proposed sale of securities
02/3/202408:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/3/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202410:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:49EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
29/2/202410:05EDGAR2Form 144 - Report of proposed sale of securities
29/2/202409:43EDGAR2Form 144 - Report of proposed sale of securities
27/2/202423:24EDGAR2Form 8-K - Current report
17/2/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202412:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202407:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202411:30GLOBEHenlius and Sermonix Announce Strategic Collaboration and..
06/1/202409:40DJNLigand Pharmaceuticals Gets FDA OK for Viral Skin Infection..
05/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202307:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202307:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202300:25EDGAR2Form 8-K - Current report
02/12/202300:20GLOBEPalvella Therapeutics and Ligand Pharmaceuticals Expand..
29/11/202301:01GLOBESermonix Pharmaceuticals Announces Five Abstracts Accepted..
10/11/202313:48EDGAR2Form 8-K/A - Current report: [Amend]
10/11/202309:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:08EDGAR2Form 8-K - Current report
07/11/202301:00GLOBESermonix Pharmaceuticals Announces JCO Precision Oncology..
19/10/202300:03EDGAR2Form 8-K - Current report
18/10/202323:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
04/10/202307:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202300:00GLOBESermonix Pharmaceuticals Shares Results of EQUALS 2 Survey..
27/9/202322:38EDGAR2Form 8-K - Current report
27/9/202306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202306:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202307:26EDGAR2Form 8-K - Current report
15/8/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:02EDGAR2Form 8-K - Current report
17/7/202322:45GLOBENovan Enters into Agreement to Sell Substantially All of its..
11/7/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202323:00GLOBESermonix Pharmaceuticals to Present Two Posters at The..
05/6/202323:01GLOBESermonix Pharmaceuticals Shares ASCO Poster Presentation on..
26/5/202307:00GLOBESermonix Pharmaceuticals to Share Longer Patient Follow-up..

Your Recent History

Delayed Upgrade Clock